Back to Authors

Madigan, Kate

Mayo Clinic

Syndax Pharmaceuticals (United States)

Citations 1

Outcomes after Transplant in Relapsed/Refractory KMT2Ar (MLLr) and mNPM1 (NPM1c) leukemia Patients Achieving Remissions after Menin Inhibition: SNDX-5613 (revumenib) Ph1 Experience
Issa, Ghayas C., Cuglievan, Branko , Stein, Eytan M. , Arellano, Martha , Khera, Nandita , Stone, Richard M. , Thirman, Michael J. , Karras, Nicole, Gu, Yu , Bagley, Rebecca G., Rosen, Galit, Tamang, David, Dishman, Kimberly, Scalera, Sushama, Meyers, Michael L., Madigan, Kate, McNeer, Nicole, Issa, Ghayas , Žučenka, Andrius , DiPersio, John F. , Madigan, Kate, Aldoss, Ibrahim

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 914-916

10.1182/blood-2022-164600 Get It